Cargando…
Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer
BACKGROUND: Colorectal cancer (CRC) is the most common malignant cancer worldwide. Sanguisorba officinalis has been shown to have anti-inflammatory, anti-bacterial, antioxidant, and anti-tumor effects, while its molecular mechanism against CRC remains unclear. The aim of this study is to explore the...
Autores principales: | Zhang, Weijia, Sang, Shuyi, Peng, Chang, Li, George Q., Ou, Ling, Feng, Zhong, Zou, Yuanjing, Yuan, Yuemei, Yao, Meicun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133337/ https://www.ncbi.nlm.nih.gov/pubmed/35646655 http://dx.doi.org/10.3389/fonc.2022.807718 |
Ejemplares similares
-
Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways
por: Zhang, Weijia, et al.
Publicado: (2023) -
In vitro anti‐bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection
por: Shen, Xue, et al.
Publicado: (2021) -
A Bioactive Compound from Sanguisorba officinalis L. Inhibits Cell Proliferation and Induces Cell Death in 5-Fluorouracil-Sensitive/Resistant Colorectal Cancer Cells
por: Zhang, Weijia, et al.
Publicado: (2021) -
Evaluation of Polyphenolic Composition and Antimicrobial Properties of Sanguisorba officinalis L. and Sanguisorba minor Scop.
por: Tocai (Moţoc), Alexandra-Cristina, et al.
Publicado: (2022) -
Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
por: Jiang, Nan, et al.
Publicado: (2021)